Navigating the Corporate Practice of Medicine in Peptide Therapy
The growing prevalence of peptide treatments presents unique complications regarding the corporate practice of medicine. Many states prohibit non-physician providers from diagnosing, addressing patients, and authorizing medications , even within a organizational setting. Consequently , knowing th